Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Breast Cancer Research : BCR|December 12, 2001
Predictive factor for the response to adjuvant therapy with emphasis in breast cancerP N Munster, L NortonAnnals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2024
Estrogens and breast cancerJ Kim, P N MunsterCancer Research|December 4, 2001
The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cellsP N Munster, T Troso-Sandoval, N Rosen, et al.Chemistry & Biology|April 18, 2001
A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cellsG Chiosis, M N Timaul, B Lucas, et al.European Journal of Cancer (Oxford, England : 1990)|July 23, 2015
Results of a phase 1 trial combining ridaforolimus and MK-0752 in patients with advanced solid tumoursS A Piha-Paul, P N Munster, A Hollebecque, et al.British Journal of Cancer|September 10, 2009
Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive markerP N Munster, D Marchion, S Thomas, et al.British Journal of Cancer|May 12, 2011
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancerP N Munster, K T Thurn, S Thomas, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 25, 2011
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapyM Campone, I Bondarenko, S Brincat, et al.British Journal of Cancer|December 1, 2011
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanomaA P Algazi, J S Weber, S C Andrews, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2016
A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcomaS Thomas, R Aggarwal, T Jahan, et al.Pageof 2